SG Americas Securities’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $101K | Sell |
9,135
-89,568
| -91% | -$1.38M | ﹤0.01% | 2933 |
|
|
2025
Q4 | $2.01M | Buy |
98,703
+92,212
| +1,421% | +$1.62M | ﹤0.01% | 1533 |
|
|
2025
Q3 | $103K | Buy |
+6,491
| New | +$95.9K | ﹤0.01% | 3071 |
|
|
2025
Q1 | – | Sell |
-24,493
| Closed | -$388K | – | 3613 |
|
|
2024
Q4 | $388K | Buy |
+24,493
| New | +$1.27M | ﹤0.01% | 1573 |
|
|
2024
Q3 | – | Sell |
-11,633
| Closed | -$532K | – | 3519 |
|
|
2024
Q2 | $532K | Buy |
+11,633
| New | +$625K | ﹤0.01% | 1649 |
|
|
2024
Q1 | – | Sell |
-12,252
| Closed | -$487K | – | 3213 |
|
|
2023
Q4 | $487K | Sell |
12,252
-34,931
| -74% | -$1.1M | 0.01% | 1502 |
|
|
2023
Q3 | $1.5M | Buy |
47,183
+38,857
| +467% | +$1.45M | 0.02% | 937 |
|
|
2023
Q2 | $335K | Sell |
8,326
-19,728
| -70% | -$865K | ﹤0.01% | 1566 |
|
|
2023
Q1 | $1.2M | Buy |
28,054
+13,949
| +99% | +$705K | 0.02% | 1020 |
|
|
2022
Q4 | $677K | Buy |
14,105
+6,079
| +76% | +$284K | 0.01% | 1276 |
|
|
2022
Q3 | $302K | Sell |
8,026
-4,771
| -37% | -$165K | ﹤0.01% | 1988 |
|
|
2022
Q2 | $354K | Buy |
12,797
+9,853
| +335% | +$432K | ﹤0.01% | 2258 |
|
|
2022
Q1 | $160K | Buy |
2,944
+243
| +9% | +$12.5K | ﹤0.01% | 2543 |
|
|
2021
Q4 | $158K | Sell |
2,701
-4,582
| -63% | -$228K | ﹤0.01% | 2792 |
|
|
2021
Q3 | $288K | Buy |
+7,283
| New | +$259K | ﹤0.01% | 2978 |
|
|
2021
Q2 | – | Sell |
-2,725
| Closed | -$168K | – | 3060 |
|
|
2021
Q1 | $168K | Buy |
+2,725
| New | +$173K | ﹤0.01% | 2790 |
|
|
2020
Q3 | – | Sell |
-4,087
| Closed | -$153K | – | 3096 |
|
|
2020
Q2 | $153K | Buy |
+4,087
| New | +$126K | ﹤0.01% | 3084 |
|
Other funds holding KROS
NCM
VCM
O
VPM
MAP